| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.32 | 2e-09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.3 | 5e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.3 | 3e-06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.25 | 5e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.02 |